desipramine has been researched along with adenosine-5'-(n-ethylcarboxamide) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reid, A; Sawynok, J | 1 |
| Koch, H; Starke, K; von Kügelgen, I | 1 |
2 other study(ies) available for desipramine and adenosine-5'-(n-ethylcarboxamide)
| Article | Year |
|---|---|
Desipramine potentiates spinal antinociception by 5-hydroxytryptamine, morphine and adenosine.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Desipramine; Dose-Response Relationship, Drug; Drug Synergism; Male; Morphine; Nociceptors; Norepinephrine; Pain Measurement; Rats; Rats, Inbred Strains; Serotonin; Spinal Cord | 1992 |
P2-receptor-mediated inhibition of serotonin release in the rat brain cortex.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Cerebral Cortex; Desipramine; Dinucleoside Phosphates; In Vitro Techniques; Male; Methiothepin; Quipazine; Rats; Rats, Wistar; Receptors, Purinergic P2; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1997 |